MENU
+Compare
MNOV
Stock ticker: NASDAQ
AS OF
Sep 4, 12:41 PM (EDT)
Price
$1.34
Change
+$0.02 (+1.52%)
Capitalization
64.74M

MNOV Medicinova Forecast, Technical & Fundamental Analysis

MediciNova Inc is a biopharmaceutical company... Show more

Industry: #Biotechnology
MNOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MNOV with price predictions
Sep 03, 2025

MNOV's Stochastic Oscillator stays in oversold zone for 1 day

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 26, 2025. You may want to consider a long position or call options on MNOV as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

MNOV moved above its 50-day moving average on August 22, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MNOV crossed bullishly above the 50-day moving average on August 05, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MNOV advanced for three days, in of 220 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 107 cases where MNOV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for MNOV turned negative on September 02, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MNOV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.382) is normal, around the industry mean (19.980). P/E Ratio (0.000) is within average values for comparable stocks, (52.119). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.122). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (476.190) is also within normal values, averaging (326.117).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MNOV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MNOV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
MNOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MNOV is expected to report earnings to fall 18.23% to -10 cents per share on November 13

Medicinova MNOV Stock Earnings Reports
Q3'25
Est.
$-0.10
Q2'25
Missed
by $0.03
Q4'24
Est.
$-0.06
Q3'24
Est.
$-0.06
Q2'24
Beat
by $0.01
The last earnings report on August 15 showed earnings per share of -12 cents, missing the estimate of -9 cents. With 12.56K shares outstanding, the current market capitalization sits at 64.74M.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which develops small molecule therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4275 Executive Square
Phone
+1 858 373-1500
Employees
13
Web
https://www.medicinova.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AIMFF2.340.02
+0.78%
Aimia, Inc.
CLOQ0.17N/A
N/A
Cyberloq Technologies Inc.
AMTPQ0.01N/A
N/A
Ameritrans Capital Corp.
BTSBF14.29N/A
N/A
Betsson AB
DSEEY7.70-0.44
-5.35%
Daiwa Securities Group, Inc.

MNOV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MNOV has been loosely correlated with FATE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MNOV jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNOV
1D Price
Change %
MNOV100%
+0.76%
FATE - MNOV
36%
Loosely correlated
-2.91%
MNKD - MNOV
30%
Poorly correlated
-4.01%
VIR - MNOV
29%
Poorly correlated
+10.20%
TIL - MNOV
28%
Poorly correlated
-0.75%
QLGN - MNOV
28%
Poorly correlated
-2.79%
More